. "Appendix F: Ethical Issues in Immunotherapies and Depot Mechanisms for Substance Abuse." New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions
Lidz, C.W., and Appelbaum, P.S. (2002). The therapeutic misconception: Problems and solutions. Medical Care,40(Suppl 9), V55-V63.
McCrady, B.S., and Bux, Jr., D.A. (1999). Ethical issues in informed consent with substance abusers. Journal of Consulting and Clinical Psychology,67(2), 186-193.
Murray, T.H. (1986). Divided loyalties dilemmas for physicians: Social context and moral problems. Social Science and Medicine,23(8), 827-832.
Murray, T.H. (1987). The growing danger from gene-spliced hormones. Discover,8(2), 88, 90, 92.
Murray, T.H. (1996). The worth of a child. Berkeley and Los Angeles: University of California Press.
National Bioethics Advisory Commission. (1998). Research involving persons with mental disorders that may affect decisionmaking capacity. Rockville, MD: National Bioethics Advisory Commission.
Nelson, R.M., and Merz, J.F. (2002). Voluntariness of consent for research: An empirical and conceptual review. Medical Care,40(Suppl 9), V69-V80.
Ross, L.F. (1997). Health care decisionmaking by children: Is it in their best interest? Hastings Center Report,27(6), 41-45.
Schaeffer, M.H., Krantz, D.S., Wichman, A., Masur, H., Reed, E., and Vinicky, J.K. (1996). The impact of disease severity on the informed consent process in clinical research. American Journal of Medicine,100(3), 261-268.
Ubel, P.A. (2002). Is information always a good thing? Helping patients make “good” decisions. Medical Care,40(Suppl 9), V39-V44.
Waggoner, W.C., and Mayo, D.M. (1995). Who understands? A survey of 25 words or phrases commonly used in proposed clinical research consent forms. IRB,17(1), 6-9.